Answers are grounded in this paper and cite their sources.
Literature review reveals clear clinical efficacy of repetitive transcranial magnetic stimulation in major depressive disorder, highlighting support for left high-frequency treatment protocols.
OBJECTIVES: First, to conduct a historical review of the evidence for repetitive transcranial magnetic stimulation (rTMS) for major depressive disorder and determine a clinical algorithm. Second, to identify opportunities for research. METHODS: Literature searches were conducted of the MEDLINE database, UpToDate and the Australian National University Library SuperSearch from 1 January 2000 to 30 September 2019. The search terms used were 'transcranial magnetic stimulation', 'major depressive disorder' and 'depression'. RESULTS: There were 24 meta-analyses identified, demonstrating a clear clinical effect. Left high-frequency rTMS had the most evidence. Ideal clinical parameters and study design were explored. CONCLUSION: Use of rTMS for some patients with depression is justified. Open research questions include the comparative efficacy of right low-frequency and bilateral stimulation, the role of rTMS in medication-naïve patients, and maintenance of effect.
No takes yet. Share an insight, caveat, or question.
Pridmore et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: